Stockreport

VivoPower Receives Nasdaq Approval of Ticker “TEMB” for Planned Tembo Listing at a Targeted Valuation of $838 Million

Meridian Bioscience Inc.  (VIVO) 
Last meridian bioscience inc. earnings: 2/7 07:25 am Check Earnings Report
US:NASDAQ Investor Relations: investor.meridianbioscience.com
PDF Ticker approval marks a key regulatory milestone for the listing of the business combination between VivoPower’s subsidiary Tembo e-LV, and Cactus Acquisition Corporatio [Read more]